Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
T
T. Burrow
High Impact
Professor
Also affiliated: Cincinnati Children's Hospital Medical Center (2006–2018); Arkansas Children's Hospital (2018–2025); University of Miami (2020); Concordia University Irvine (1935); University of Arkansas Medical Center (2020); Lankenau Heart Institute (2017); Science Oxford (1957); Woodlands Hospital (1980); Christ University (1935); University of Cincinnati (2007–2012); University of Newcastle Australia (2012); University of Cincinnati Medical Center (2007–2010)
Faculty Researcher
21 h-index
197 pubs
1,279 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
T. Burrow's research centers on the diagnosis, management, and progression of various genetic and metabolic disorders, with a particular focus on Gaucher disease and Pompe disease. Burrow has investigated the long-term efficacy and safety of therapeutic interventions for late-onset Pompe disease, including studies on cipaglucosidase alfa in combination with miglustat. Additionally, Burrow's work addresses the complexities of diagnosing and managing glycogen storage disease type IV and Wolman disease, especially in pediatric populations. The researcher has also explored the impact of the COVID-19 pandemic on specific patient communities, such as individuals with Gaucher disease in the US.
Further research interests include mitochondrial ultrastructural defects and the genetic underpinnings of neurodevelopmental disorders, as evidenced by work on NDUFS3-related disorders and variants in the BSN gene. Burrow's scholarship metrics include an h-index of 21, 197 total publications, and 1,262 total citations, with a designation as a highly cited researcher. Collaborations within the University of Arkansas for Medical Sciences include Thomas Andrew Burrow, Carissa Rodriquez, Hannah Barkley, and Ankita Shukla.
Metrics
- h-index: 21
- Publications: 197
- Citations: 1,279
Selected Publications
-
Diagnostic Odyssey of Atypical Long‐Chain 3‐Hydroxyacyl‐ <scp>CoA</scp> Dehydrogenase Deficiency ( <scp>LCHADD</scp> ) Explained by Three Allelic Products From Two Pathogenic Variants (2026)
-
Central nervous system-symptomatic hyperammonemia following recombinant crisantaspase Pseudomonas fluorescens (2026)
-
Longitudinal Observation of Children with Achondroplasia: Findings from a Global Natural History Study (ACHieve) (2026)
-
Variants in BSN, encoding the presynaptic protein Bassoon, result in a distinct neurodevelopmental disorder with a broad phenotypic range (2025)
-
Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2025)
-
Variants in <i>BSN</i> , encoding the presynaptic protein Bassoon, result in a novel neurodevelopmental disorder with a broad phenotypic range (2025)
-
Neurodevelopmental delay, musculoskeletal disorders and dysmorphia associated with a novel pathogenic interstitial deletion of chromosome 10q21.1q21.3 (2025)
-
Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2024)
-
04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations (2024)
-
Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency (2024)
-
DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY (2023)
-
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource (2023)
-
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly (2022)
-
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? (2022)
-
Mitochondrial Ultrastructural Defects in NDUFS3-Related Disorder (2021)
Collaboration Network
Top Collaborators
Priya S. Kishnani
Duke Medical Center (US)
3 shared publications
- The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly
Nicola Longo
University of Utah (US)
3 shared publications
- The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
- DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY
- Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency
Hannah Barkley
University of Arkansas for Medical Sciences
3 shared publications
In database
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- 04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Carissa Rodriquez
Arkansas Children's Hospital
3 shared publications
In database
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- 04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Karl E. Anderson
The University of Texas Medical Branch at Galveston (US)
3 shared publications
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- 04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Surekha Pendyal
Duke Medical Center (US)
2 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly
Laura Konczal
University Hospitals of Cleveland (US)
2 shared publications
- DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY
- Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency
Marie Luz Couce
Universidade de Santiago de Compostela (ES)
2 shared publications
- DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY
- Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency
Mireia del Toro
Vall d'Hebron Hospital Universitari (ES)
2 shared publications
- DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY
- Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency
Gerald S. Lipshutz
University of California, Los Angeles (US)
2 shared publications
- DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY
- Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency
J. Lawrence Merritt
Ultragenyx Pharmaceutical (United States) (US)
2 shared publications
- DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY
- Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency
Alexis N. Roach
Arkansas Children's Hospital
2 shared publications
In database
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Ankita Shukla
Arkansas Children's Hospital
2 shared publications
In database
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Stacy Guzman
Children's Hospital of Philadelphia (US)
2 shared publications
- Variants in BSN, encoding the presynaptic protein Bassoon, result in a distinct neurodevelopmental disorder with a broad phenotypic range
- Variants in <i>BSN</i> , encoding the presynaptic protein Bassoon, result in a novel neurodevelopmental disorder with a broad phenotypic range
Sarah M. Ruggiero
Children's Hospital of Philadelphia (US)
2 shared publications
- Variants in BSN, encoding the presynaptic protein Bassoon, result in a distinct neurodevelopmental disorder with a broad phenotypic range
- Variants in <i>BSN</i> , encoding the presynaptic protein Bassoon, result in a novel neurodevelopmental disorder with a broad phenotypic range
Similar Researchers
Based on overlapping research topics
Elizabeth A. Sellars
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Pharmacological Effects and Toxicity Studies
Alexander Kwok
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
COVID-19 Clinical Research Studies
W. Du
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Pharmacological Effects and Toxicity Studies
Eniya Beemarajan
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Pharmacological Effects and Toxicity Studies
Katherine B. Bosanko
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Medical Case Studies
Kapil Arya
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Medical Case Studies